Bipriya Biotechnology Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 15.61%
- Profit Growth 147.33%
- Ebitda 255.63%
- Net Worth 2.60%
- Total Assets 2.99%
About Bipriya Biotechnology
Bipriya Biotechnology Private Limited (BBPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 December 2019 (Five years and one month 22 days old ). Its registered office is in North 24 Parganas, West Bengal, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pinki Das and Biswajit Das serve as directors at the Company.
Company Details
-
Location
North 24 Parganas, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52500WB2019PTC235243
-
Company No.
235243
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Dec 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Bipriya Biotechnology?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pinki Das
|
Director | 12-Dec-2019 | Current |
|
Biswajit Das
|
Director | 12-Dec-2019 | Current |
Financial Performance of Bipriya Biotechnology.
Bipriya Biotechnology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.61% increase. The company also saw a substantial improvement in profitability, with a 147.33% increase in profit. The company's net worth moved up by a moderate rise of 2.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bipriya Biotechnology?
Unlock access to Bipriya Biotechnology's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
New Aaghrani Banga Mutual Benefit Nidhi LimitedPinki Das is a mutual person
-
Agrani Nidhi Limited
Pinki Das is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bipriya Biotechnology?
Unlock and access historical data on people associated with Bipriya Biotechnology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bipriya Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bipriya Biotechnology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.